Some enzymic aspects of the production of oxidized or reduced metabolites of catecholamines and 5-hydroxytryptamine by brain tissues.
D000429:Alcohol Oxidoreductases / Q000378:metabolism*; D000445:Aldehyde Oxidoreductases / Q000378:metabolism*; D000447:Aldehydes; D000818:Animals; D001921:Brain / Q000201:enzymology*; D002395:Catecholamines / Q000378:metabolism*; D002421:Caudate Nucleus / Q000201:enzymology; D002540:Cerebral Cortex / Q000201:enzymology; D002848:Chromatography, DEAE-Cellulose; D002850:Chromatography, Gel; D004298:Dopamine / Q000378:metabolism; D004355:Drug Stability; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D008099:Liver / Q000201:enzymology; D009638:Norepinephrine / Q000378:metabolism; D009928:Organ Specificity; D012701:Serotonin / Q000378:metabolism*; D012995:Solubility; D013056:Spectrophotometry, Ultraviolet; D013329:Structure-Activity Relationship; D013552:Swine
D000447:Aldehydes; D002395:Catecholamines; D012701:Serotonin; D000429:Alcohol Oxidoreductases; D000445:Aldehyde Oxidoreductases; D004298:Dopamine; D009638:Norepinephrine